Clinical Outsourcing Group Europe

At close to €350 billion, the value of the European biopharmaceutical market is second only to the US.  But with different nations working on different rules and regulations, drug discovery and clinical development across borders aren’t always straightforward. This has bred a unique ecosystem of biopharma companies served by innovative solution providers on a local, continental and global level.​

COG Europe brings together senior decision-makers across from all four corners of Europe to hear from thought leaders within industry, regulators, and academia alongside a group of the most trusted and innovative solution providers serving the European market for two days of leading multi-stream agenda content and networking engagement at a luxury Milan hotel.